Scott Wolchko | President & Chief Executive Officer |
Wayne Chu | Senior Vice President, Clinical Development |
Ted Tenthoff | Piper Sandler |
Robyn Karnauskas | SunTrust Robinson |
Jim Birchenough | Wells Fargo |
Alethia Young | Cantor |
Daina Graybosch | SVB Leerink |
David Nierengarten | Wedbush Securities |
Biren Amin | Jefferies |
Mara Goldstein | Mizuho |
Ben Burnett | Stifel |
Michael Schmidt | Guggenheim |
Peter Lawson | Barclays |
Welcome to the Fate Therapeutics' First Quarter 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors and Media section of Fate's website at fatetherapeutics.com.
As a reminder, today's call is being recorded.
I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics.